Powered by Max Banner Ads 
Anticonvulsant studied for primary insomnia.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 732 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Anticonvulsant studied for primary insomnia.(Clinical Rounds)
Author: Patrice Wendling
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 3 Page: 88(1)

Distributed by Thomson Gale

Abundance of insomnia drugs in the pipeline.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 1, 2005. The length of the article is 1046 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Abundance of insomnia drugs in the pipeline.(Clinical Rounds)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: November 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 21 Page: 75(1)

Distributed by Thomson Gale

FDA approves eszopiclone to treat insomnia.(News): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 379 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA approves eszopiclone to treat insomnia.(News)
Author: Alicia Ault
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 3 Page: 14(1)

Distributed by Thompson Gale

Short half-life sets investigational drug for insomnia apart.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2004. The length of the article is 773 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Short half-life sets investigational drug for insomnia apart.(Clinical Rounds)
Author: Mitchel L. Zoler
Publication: Family Practice News (Magazine/Journal)
Date: September 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 18 Page: 50(1)

Distributed by Thomson Gale

Consider Duration, Onset of Action When Choosing an Insomnia Agent.(benzodiazepine receptors)(Brief Article): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on April 1, 2000. The length of the article is 1499 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Consider Duration, Onset of Action When Choosing an Insomnia Agent.(benzodiazepine receptors)(Brief Article)Author: Doug BrunkPublication: Family Practice News (Magazine/Journal)Date: April 1, 2000Publisher: International Medical News GroupVolume: 30 Issue: 7 Page: 28Article Type:... [Read More]

Eszopiclone consistently effective for insomnia.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on August 1, 2004. The length of the article is 862 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Eszopiclone consistently effective for insomnia.(Clinical Rounds)
Author: Patrice G.W. Norton
Publication: Family Practice News (Magazine/Journal)
Date: August 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 15 Page: 52(1)

Distributed by Thomson Gale

Novel drug cuts insomnia; no drowsiness or rebound.(Mental Health)(eplivanserin): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $9.95
Sale Price: $9.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 15, 2008. The length of the article is 367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Novel drug cuts insomnia; no drowsiness or rebound.(Mental Health)(eplivanserin)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: November 15, 2008
Publisher: International Medical News Group
Volume: 38 Issue: 22 Page: 19(1)

Distributed by Gale, a part of Cengage Learning

Long-Term Zaleplon Appears Safe, Effective for Sleep Disorder.: An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 15, 1999. The length of the article is 361 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Long-Term Zaleplon Appears Safe, Effective for Sleep Disorder.Author: Carl ShermanPublication: Family Practice News (Magazine/Journal)Date: November 15, 1999Publisher: International Medical News GroupVolume: 29 Issue: 22 Page: 45Article Type: Product/Service EvaluationDistributed by Thomson... [Read More]

  

Switch to our mobile site